
    
      The investigators are trying to set up voriconazole (VCZ) therapeutic drug monitoring (TDM) &
      establish relationship with efficacy and safety in Korea. The investigators also want to
      propose the optimal dosage regimen for VCZ over different genotypes of CYP2C19 in the
      immunocompromised patients in Korea.
    
  